Literature DB >> 23187774

PD-1-targeted immunotherapy: recent clinical findings.

Julie R Brahmer1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23187774

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


× No keyword cloud information.
  24 in total

Review 1.  The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention.

Authors:  Joanna Domagala-Kulawik
Journal:  Transl Lung Cancer Res       Date:  2015-04

2.  ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression.

Authors:  Huanling Zhang; Yanyan Li; Xiaoping Liu; Zhaoduan Liang; Mengyong Yan; Qiang Liu; Anan Chen; Yifeng Bao; Chengzhi Zhou; Shiyue Li; Cassian Yee; Yi Li
Journal:  Immunology       Date:  2018-06-14       Impact factor: 7.397

Review 3.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

4.  Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

Authors:  Manisha Singh; Hiep Khong; Zhimin Dai; Xue-Fei Huang; Jennifer A Wargo; Zachary A Cooper; John P Vasilakos; Patrick Hwu; Willem W Overwijk
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

5.  Leveraging immunochemotherapy for treating pancreatic cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Cell Res       Date:  2021-12       Impact factor: 25.617

Review 6.  ImmunoPET: harnessing antibodies for imaging immune cells.

Authors:  Anna M Wu; Neeta Pandit-Taskar
Journal:  Mol Imaging Biol       Date:  2021-09-22       Impact factor: 3.488

Review 7.  Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances.

Authors:  B Harpreet Singh; James L Gulley
Journal:  Ther Adv Vaccines       Date:  2014-09

8.  Specific increase in potency via structure-based design of a TCR.

Authors:  Karolina Malecek; Arsen Grigoryan; Shi Zhong; Wei Jun Gu; Laura A Johnson; Steven A Rosenberg; Timothy Cardozo; Michelle Krogsgaard
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

9.  TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.

Authors:  Ellen J Beswick; Jameel R Johnson; Jamal I Saada; Martin Humen; Jenifer House; Sara Dann; Suimin Qiu; Allan R Brasier; Don W Powell; Victor E Reyes; Irina V Pinchuk
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

Review 10.  The role of cancer stem cells in the modulation of anti-tumor immune responses.

Authors:  Cristina Maccalli; Kakil Ibrahim Rasul; Mamoun Elawad; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2018-09-24       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.